General Information of Drug (ID: DMDMU01)

Drug Name
PMID24775305C7u Drug Info
Synonyms GTPL8633; BDBM50015362
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
90656796
TTD Drug ID
DMDMU01

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Legumain (LGMN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Legumain-cleavable doxorubicin prodrugs DMEUGZL Solid tumour/cancer 2A00-2F9Z Phase 2/3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Legumain (LGMN) TTPTWV5 LGMN_HUMAN Inhibitor [1]

References

1 P3 SAR exploration of biphenyl carbamate based Legumain inhibitors. Bioorg Med Chem Lett. 2014 Jun 1;24(11):2521-4.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2380).